Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5026
Motley Fool 100 Index ETF
TMFC
$2.13B
| $726K | ﹤0.01% |
13,048
-2,160
| -14% | -$128K |
|
5027
Vanguard US Momentum Factor ETF
VFMO
$1.94B
| $726K | ﹤0.01% |
4,783
-218
| -4% | -$35.9K |
|
5028
AltShares Merger Arbitrage ETF
ARB
$102M
| $723K | ﹤0.01% |
25,615
+11,546
| +82% | +$323K |
|
|
EEA
5029
European Equity Fund
EEA
$76.8M
| $723K | ﹤0.01% |
79,409
-4,199
| -5% | -$37.1K |
|
5030
Red Robin
RRGB
$183M
| $722K | ﹤0.01% |
202,864
+96,363
| +90% | +$494K |
|
|
LAZR
5031
DELISTED
Luminar Technologies
LAZR
| $718K | ﹤0.01% |
133,172
-170,117
| -56% | -$1.03M |
|
5032
Avita Medical
RCEL
$248M
| $716K | ﹤0.01% |
88,013
+3,097
| +4% | +$28.9K |
|
5033
Outset Medical
OM
$79.9M
| $716K | ﹤0.01% |
64,694
-31,057
| -32% | -$370K |
|
5034
Global Water Resources
GWRS
$256M
| $713K | ﹤0.01% |
69,181
+1,088
| +2% | +$12.4K |
|
5035
Riskified
RSKD
$863M
| $712K | ﹤0.01% |
154,167
+57,635
| +60% | +$290K |
|
|
ABX
5036
Abacus Global Management
ABX
$833M
| $710K | ﹤0.01% |
94,855
+75,753
| +397% | +$575K |
|
|
NRT
5037
North European Oil Royalty Trust
NRT
$83.6M
| $710K | ﹤0.01% |
147,688
-9,379
| -6% | -$43.9K |
|
5038
Immuneering
IMRX
$336M
| $710K | ﹤0.01% |
467,226
+13,126
| +3% | +$23.8K |
|
5039
Orange County Bancorp
OBT
$524M
| $709K | ﹤0.01% |
30,313
-8,553
| -22% | -$219K |
|
5040
Savara
SVRA
$1.08B
| $708K | ﹤0.01% |
255,513
-140,445
| -35% | -$388K |
|
5041
iShares MSCI Norway ETF
ENOR
$101M
| $708K | ﹤0.01% |
27,273
+1,216
| +5% | +$29.4K |
|
5042
Prime Medicine
PRME
$575M
| $707K | ﹤0.01% |
355,176
+43,900
| +14% | +$112K |
|
5043
BayCom
BCML
$339M
| $704K | ﹤0.01% |
27,963
-11,583
| -29% | -$310K |
|
5044
Townsquare Media
TSQ
$104M
| $703K | ﹤0.01% |
86,315
+10,636
| +14% | +$92.4K |
|
5045
RGC Resources
RGCO
$226M
| $702K | ﹤0.01% |
33,642
-8,937
| -21% | -$184K |
|
|
SLI
5046
Standard Lithium
SLI
$574M
| $702K | ﹤0.01% |
552,843
+256,378
| +86% | +$372K |
|
|
TRVG
5047
trivago
TRVG
$365M
| $694K | ﹤0.01% |
169,342
+24,129
| +17% | +$88.8K |
|
|
IPX
5048
IperionX
IPX
$870M
| $691K | ﹤0.01% |
38,397
+22,647
| +144% | +$566K |
|
5049
Roundhill Ball Metaverse ETF
METV
$213M
| $691K | ﹤0.01% |
51,186
-1,202
| -2% | -$17.6K |
|
5050
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$327M
| $690K | ﹤0.01% |
9,695
+4,297
| +80% | +$270K |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.